Developmental pharmacology of aminoglycosides and vancomycin

Gideon Koren; Julia Klein; Monica Bologa

doi:10.1201/9781351071529

Developmental pharmacology of aminoglycosides and vancomycin

Gideon Koren
, Julia Klein
, Monica Bologa

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Aminoglycosides are the most widely used antibiotics in the neonatal intensive care unit for the treatment of Gram-negative septicemia, meningitis, and necrotizing enterocolitis. Later in infancy and childhood, they are used to treat the bacteremia-septicemia of the immunosuppressed and Gram-negative infections complicating cystic fibrosis. The use of vancomycin as an antistaphylococcal agent has emerged recently parallel to the development of staphylococcal resistance against the penicillins.

Original language	English
Title of host publication	Drug Toxicity and Metabolism in Pediatrics
Pages	173-184
Number of pages	12
ISBN (Electronic)	9781351079976
DOIs	https://doi.org/10.1201/9781351071529
State	Published - 1 Jan 2018
Externally published	Yes

Access to Document

10.1201/9781351071529

Cite this

@inbook{2f40fd1d9e69438c8c072ad816ada946,

title = "Developmental pharmacology of aminoglycosides and vancomycin",

abstract = "Aminoglycosides are the most widely used antibiotics in the neonatal intensive care unit for the treatment of Gram-negative septicemia, meningitis, and necrotizing enterocolitis. Later in infancy and childhood, they are used to treat the bacteremia-septicemia of the immunosuppressed and Gram-negative infections complicating cystic fibrosis. The use of vancomycin as an antistaphylococcal agent has emerged recently parallel to the development of staphylococcal resistance against the penicillins.",

author = "Gideon Koren and Julia Klein and Monica Bologa",

note = "Publisher Copyright: {\textcopyright} 1990 by CRC Press, Inc.",

year = "2018",

month = jan,

day = "1",

doi = "10.1201/9781351071529",

language = "אנגלית",

isbn = "9781315892429",

pages = "173--184",

booktitle = "Drug Toxicity and Metabolism in Pediatrics",

}

TY - CHAP

T1 - Developmental pharmacology of aminoglycosides and vancomycin

AU - Koren, Gideon

AU - Klein, Julia

AU - Bologa, Monica

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Aminoglycosides are the most widely used antibiotics in the neonatal intensive care unit for the treatment of Gram-negative septicemia, meningitis, and necrotizing enterocolitis. Later in infancy and childhood, they are used to treat the bacteremia-septicemia of the immunosuppressed and Gram-negative infections complicating cystic fibrosis. The use of vancomycin as an antistaphylococcal agent has emerged recently parallel to the development of staphylococcal resistance against the penicillins.

AB - Aminoglycosides are the most widely used antibiotics in the neonatal intensive care unit for the treatment of Gram-negative septicemia, meningitis, and necrotizing enterocolitis. Later in infancy and childhood, they are used to treat the bacteremia-septicemia of the immunosuppressed and Gram-negative infections complicating cystic fibrosis. The use of vancomycin as an antistaphylococcal agent has emerged recently parallel to the development of staphylococcal resistance against the penicillins.

UR - https://www.scopus.com/pages/publications/84910802925

U2 - 10.1201/9781351071529

DO - 10.1201/9781351071529

M3 - ???researchoutput.researchoutputtypes.contributiontobookanthology.chapter???

AN - SCOPUS:84910802925

SN - 9781315892429

SP - 173

EP - 184

BT - Drug Toxicity and Metabolism in Pediatrics

ER -

Developmental pharmacology of aminoglycosides and vancomycin

Abstract

Access to Document

Other files and links

Fingerprint

Cite this